Page last updated: 2024-10-28

hydroxychloroquine and Deaf Mutism

hydroxychloroquine has been researched along with Deaf Mutism in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research Excerpts

ExcerptRelevanceReference
"Sensorineural deafness has previously been reported with chloroquine treatment, but this is the first report of ototoxicity associated with HQ in RA."5.31Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis. ( Borman, P; Bostan, EE; Ikinciogullari, A; Ozoran, K; Seçkin, U, 2000)
"Sensorineural deafness has previously been reported with chloroquine treatment, but this is the first report of ototoxicity associated with HQ in RA."1.31Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis. ( Borman, P; Bostan, EE; Ikinciogullari, A; Ozoran, K; Seçkin, U, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seçkin, U1
Ozoran, K1
Ikinciogullari, A1
Borman, P1
Bostan, EE1

Other Studies

1 other study available for hydroxychloroquine and Deaf Mutism

ArticleYear
Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis.
    Rheumatology international, 2000, Volume: 19, Issue:5

    Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Deafness; Female; Humans; Hydroxychloroquine

2000